Published in FEMS Microbiol Lett on January 01, 1990
Gonococci in vivo: Host CMP-NANA, sialylated lipopolysaccharide and serum resistance. Can J Infect Dis (1993) 0.75
The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med (1978) 15.13
General practitioner's perceptions of the route to evidence based medicine: a questionnaire survey. BMJ (1998) 13.39
Antibodies to ribosomes in chronic active hepatitis. Gastroenterology (1979) 12.78
Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies. J Clin Pathol (1984) 10.23
Randomized versus historical controls for clinical trials. Am J Med (1982) 7.53
Performance indicators for primary care groups: an evidence based approach. BMJ (1998) 6.97
A method for assessing the quality of a randomized control trial. Control Clin Trials (1981) 6.63
Serological response to Campylobacter jejuni/coli infection. J Clin Pathol (1980) 6.01
Microbial surfaces in relation to pathogenicity. Bacteriol Rev (1977) 5.79
Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med (2000) 5.68
Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population. J Med Microbiol (1986) 4.95
Bias in treatment assignment in controlled clinical trials. N Engl J Med (1983) 4.78
Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ (2010) 4.53
The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect (1987) 4.40
Publication bias and clinical trials. Control Clin Trials (1987) 4.34
Serotyping of Campylobacter jejuni/coli. J Clin Pathol (1980) 4.22
Milk-borne campylobacter infection. Br Med J (Clin Res Ed) (1981) 4.15
Water-borne outbreak of campylobacter gastroenteritis. Lancet (1983) 3.97
Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest (1996) 3.74
MR imaging and T2 mapping of femoral cartilage: in vivo determination of the magic angle effect. AJR Am J Roentgenol (2001) 3.69
The regulation of metabolism in facultative bacteria. 3. The effect of nitrate. Biochim Biophys Acta (1967) 3.68
New spiral bacterium in gastric mucosa. J Clin Pathol (1989) 3.61
Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA (1995) 3.48
Giardia and Cryptosporidium join the 'Neglected Diseases Initiative'. Trends Parasitol (2006) 3.34
Future provision of out of hours primary medical care: a survey with two general practitioner research networks. BMJ (1996) 3.34
A novel and ubiquitous system for membrane targeting and secretion of cofactor-containing proteins. Cell (1998) 3.33
Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med (1977) 3.33
Paediatric intensive care transfers. Anaesthesia (2000) 3.32
Recruitment of a penicillin-binding protein gene from Neisseria flavescens during the emergence of penicillin resistance in Neisseria meningitidis. Proc Natl Acad Sci U S A (1989) 3.22
ACP Broadsheet 121: June 1989. Investigation of meningococcal disease. J Clin Pathol (1989) 3.09
Intraoperative bacterial contamination in operations for joint replacement. J Bone Joint Surg Br (1999) 3.07
Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med (1983) 3.04
Appropriateness of use of emergency ambulances. J Accid Emerg Med (1998) 3.02
Rate of regeneration of peripheral nerves in man. J Physiol (1943) 3.02
Transgene-mediated auxin overproduction in Arabidopsis: hypocotyl elongation phenotype and interactions with the hy6-1 hypocotyl elongation and axr1 auxin-resistant mutants. Plant Mol Biol (1995) 3.01
Meningococcal infections in Bolton, 1971-74. Lancet (1975) 2.98
Cross-modal, auditory-visual Stroop interference: a reply to Cowan and Barron (1987). Percept Psychophys (1989) 2.95
Infection and diabetes: the case for glucose control. Am J Med (1982) 2.90
Is perinatal mortality still a good indicator of perinatal care? Paediatr Perinat Epidemiol (1988) 2.87
Pathogenicity of influenza virus. Microbiol Rev (1980) 2.80
Meningococcal serotypes and serogroup B disease in north-west Europe. Lancet (1986) 2.76
Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol Infect (1997) 2.67
Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65
Cryptosporidium species a "new" human pathogen. J Clin Pathol (1985) 2.63
A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry (1988) 2.63
Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature (1992) 2.61
In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J Exp Med (1990) 2.61
A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. N Engl J Med (1981) 2.59
Point mutation in meningococcal por A gene associated with increased endemic disease. Lancet (1991) 2.54
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
Penicillin-insensitive meningococci in the UK. Lancet (1988) 2.43
The chromosomal location and pleiotropic effects of mutations of the nirA+ gene of Escherichia coli K12: the essential role of nirA+ in nitrite reduction and in other anaerobic redox reactions. J Gen Microbiol (1978) 2.39
Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7. BMJ (1989) 2.39
Derivatives of 6-aminopenicillanic acid. XI. Alpha-amino-p-hydroxybenzylpenicillin. J Chem Soc Perkin 1 (1971) 2.39
Control of meningococcal disease. BMJ (1989) 2.37
Genetic engineering of harvest index in tobacco through overexpression of a phytochrome gene. Nat Biotechnol (1996) 2.36
Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess (2009) 2.36
Overnight calls in primary care: randomised controlled trial of management using nurse telephone consultation. BMJ (1999) 2.32
Phytochrome and photomorphogenesis in plants. Nature (1970) 2.26
The epidemiology of meningococcal infections in England and Wales, 1912-1983. J Infect (1985) 2.22
Metabolic pathways for nitrate reduction in Escherichia coli. Biochim Biophys Acta (1968) 2.21
Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet (1984) 2.19
Earthquake injuries related to housing in a guatemalan village. Science (1977) 2.18
Clinical governance in primary care groups: the feasibility of deriving evidence-based performance indicators. Qual Health Care (2000) 2.16
Preventive care for patients following myocardial infarction. The Wessex Research Network (WReN). Fam Pract (1997) 2.15
Biochemical challenge of microbial pathogenicity. Bacteriol Rev (1968) 2.14
Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene (2007) 2.14
Rapid improvement of peak flow in asthmatic patients treated with parenteral methylprednisolone in the emergency department: A randomized controlled study. Ann Emerg Med (1999) 2.08
A comparison of biotypes and serotypes of Campylobacter sp. isolated from patients with enteritis and from animal and environmental sources. J Infect (1984) 2.07
Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination. Lancet (1995) 2.06
The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med (1978) 2.05
Women's views about management and cause of urinary tract infection: qualitative interview study. BMJ (2010) 2.03
A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol (1990) 2.01
Recovery of viable but non-culturable Campylobacter jejuni. J Gen Microbiol (1991) 2.00
Influenza A and meningococcal disease. Lancet (1991) 2.00
Asymptomatic liver disease in hepatitis B antigen carriers. J Clin Pathol (1974) 2.00
Cost analysis of nurse telephone consultation in out of hours primary care: evidence from a randomised controlled trial. BMJ (2000) 1.99
Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet (1988) 1.98
An outbreak of meningococcal disease in Stonehouse: planning and execution of a large-scale survey. Epidemiol Infect (1987) 1.95
Groin hernia repair in Scotland. Br J Surg (2000) 1.93
Detection of herpes-simplex viral genome in brain tissue. Lancet (1979) 1.90
Food intolerance and the irritable bowel syndrome. Gut (1989) 1.88
An outbreak of presumptive food-borne campylobacter enteritis. J Infect (1981) 1.87
Micro-organisms in gastroenteritis. Arch Dis Child (1984) 1.86
Selection from gonococci grown in vitro of a colony type with some virulence properties of organisms adapted in vivo. J Gen Microbiol (1977) 1.85
Anthrax toxic complex. Fed Proc (1967) 1.84
Meningococci with reduced susceptibility to penicillin. Lancet (1990) 1.83
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation (2001) 1.82
Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. Microb Pathog (1988) 1.81
An ultrastructural study of the gastric campylobacter-like organism 'Campylobacter pyloridis'. J Gen Microbiol (1985) 1.81
Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid. Microb Pathog (1989) 1.80